Hematology & Oncology Doctors in Savannah, GA Accepting Medicare

7 Hematology & Oncology doctors found. Showing 1 - 7

Dr. Grant Carlton Lewis, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 225 Candler Dr, Suite 300, Savannah, GA 31405 Phone: 912-354-6187    Fax: 912-355-0596

Stephen A White, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 225 Candler Dr Ste 300, Savannah, GA 31405 Phone: 912-354-6187

Mark A. Taylor, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 225 Candler Dr, Suite 300, Savannah, GA 31405 Phone: 912-354-6187    Fax: 912-355-0596

Dr. Ronald F. Goldberg, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 225 Candler Dr, Suite 300, Savannah, GA 31405 Phone: 912-354-6187    Fax: 912-355-0596

Dr. Barry D. Luskey, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4700 Waters Ave, Suite A, Savannah, GA 31404 Phone: 912-354-6187    Fax: 912-354-6765

Dr. Lester E. Robertson, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4700 Waters Ave Ste A, Suite A, Savannah, GA 31404 Phone: 912-354-6187    Fax: 912-354-6765

Dr. Harvey C. Lebos, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 4700 Waters Ave, Suite A, Savannah, GA 31404 Phone: 912-354-6187    Fax: 912-355-9807

News Archive

AMHN now available via Standard & Poor's Market Access Program

AMHN, Inc., parent company of America's Minority Health Network, Inc. ("America's Minority Health Network"), announced today that its company information is now available via Standard & Poor's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of Standard & Poor's Advisor Insight.

Celera applies CE mark to real-time PCR test for detection of variant in KIF6 gene

Celera Corporation today announced that it has signed a Declaration of Conformity and applied the CE mark to a real-time PCR (polymerase chain reaction) test for detection of a variant in the KIF6 gene, allowing the test to be marketed in the European Union and other geographic areas that recognize the CE Mark.

Research clarifies origin of mammalian network of lymphatic vessels

Investigators at St. Jude Children's Research Hospital settled a century-old debate on the origin of the mammalian lymphatic vasculature - the network of vessels and capillaries critical to various essential housekeeping functions in the body.

Novel androgens play major role in development of PCOS, research shows

Scientists led by the University of Birmingham have discovered that a new class of male sex hormones known as androgens plays a key role in the development of polycystic ovary syndrome (PCOS).

Read more Medical News

› Verified 5 days ago